Is steroid use recommended in this case of shock with hypoglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Steroid Use in Shock with Hypoglycemia

In a patient with shock and hypoglycemia, low-dose hydrocortisone (≤200 mg/day) may be considered if the shock is septic in nature and requires vasopressor support, but high-dose steroids should be avoided, and the hypoglycemia must be aggressively corrected first with dextrose solutions before steroid administration. 1

Clinical Decision Algorithm

Step 1: Determine the Type of Shock

  • If septic shock requiring vasopressors: Low-dose hydrocortisone may be appropriate 1
  • If sepsis without shock: Corticosteroids are NOT recommended 1
  • If other shock etiologies: Follow traditional adrenal insufficiency guidelines only if indicated 1

Step 2: Address the Hypoglycemia FIRST

  • Do NOT use insulin if blood glucose cannot be measured regularly 1
  • Correct hypoglycemia immediately with intravenous dextrose before considering steroids 1
  • Monitor blood glucose closely as steroids will significantly worsen hyperglycemia once hypoglycemia is corrected 1, 2

Step 3: Steroid Dosing if Indicated for Septic Shock

Low-dose hydrocortisone protocol:

  • Use hydrocortisone ≤200 mg/day (typically 200 mg/day divided or continuous infusion) 1
  • Prefer continuous infusion over bolus dosing to minimize glucose fluctuations 1
  • Do NOT use high-dose steroids (e.g., hydrocortisone ≥300 mg/day or prednisolone ≥75 mg/day) as they increase mortality risk through infections, hyperglycemia, and gastrointestinal bleeding 1

Step 4: Consider Adrenal Insufficiency

  • An inappropriately low random cortisol level (<18 µg/dL) in shock is an indication for steroid therapy per traditional adrenal insufficiency guidelines 1
  • Do NOT use ACTH stimulation testing to guide steroid decisions in septic shock 1
  • If history of chronic steroid use or known adrenal dysfunction, steroids are indicated regardless 1

Critical Management Considerations

Glucose Monitoring Strategy

  • Implement frequent capillary glucose measurements (every 1-2 hours initially) once steroids are started 2
  • Target blood glucose 140-180 mg/dL in hospitalized patients 2
  • Peak hyperglycemia occurs 7-9 hours after steroid administration, particularly in afternoon/evening 1, 2

Insulin Management with Steroids

  • Use a more resistant sliding scale insulin regimen to address steroid-induced insulin resistance 2
  • Consider isophane insulin 0.1-0.3 units/kg/day if persistent hyperglycemia develops 2
  • When steroids are tapered or discontinued, rapidly reduce insulin to prevent hypoglycemia 2

Duration and Tapering

  • Taper steroids when vasopressors are no longer required 1
  • Taper over several days rather than abrupt cessation to avoid hemodynamic rebound 1

Common Pitfalls to Avoid

  • Never use high-dose steroids as they increase hospital-acquired infections, hyperglycemia, GI bleeding, and delirium without mortality benefit 1
  • Do not use hypotonic fluids (glucose solutions) for fluid resuscitation in shock 1
  • Avoid etomidate for intubation if steroids will be used, as it suppresses the HPA axis and increases 28-day mortality 1
  • Do not underestimate the additive hyperglycemic effects when dextrose solutions and steroids are used simultaneously 2
  • Never continue the same insulin regimen after steroid discontinuation as this leads to severe hypoglycemia 2

Special Circumstances

If the patient has pre-existing diabetes or develops steroid-induced hyperglycemia:

  • Basal-bolus insulin regimen may be needed at 0.3-0.5 units/kg split 50/50 between long-acting and rapid-acting insulin 1
  • Metformin can be added if renal and hepatic function are preserved 1
  • Do not use sulfonylureas for steroid-induced hyperglycemia 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hyperglycemia with D10W and Hydrocortisone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.